The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Poly(ADP-Ribose) Polymerase Inhibitors (PARPi) for patients (pts) with locally advanced or metastatic breast cancer (BC): A meta-analysis.
 
Martin Tio
No Relationships to Disclose
 
Sujata Patil
No Relationships to Disclose
 
Tiffany A. Traina
Consulting or Advisory Role - Advaxis; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Celgene; Eisai; Genentech/Roche; Genomic Health; Innocrin Pharma; Medivation; Merck; Pfizer; Puma Biotechnology; Samsung
Speakers' Bureau - Roche/Genentech
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Eisai (Inst); Innocrin Pharma (Inst); Medivation (Inst); Novartis (Inst); Pfizer (Inst)
 
Mark E. Robson
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca; McKesson
Research Funding - AbbVie (Inst); AstraZeneca (Inst); InVitae (Inst); Medivation (Inst); Myriad Genetics (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Mustafa Khasraw
Honoraria - Pfizer
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Lilly
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); Specialised Therapeutics (Inst)